Analysts have been eager to weigh in on the Healthcare sector with new ratings on DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX).......

In a report released yesterday, Keay Nakae from Chardan Capital reiterated a Buy rating on Ibio, with a price target of $5.00. Nakae covers the Hea......

Ibio ( ($IBIO) ) has shared an announcement. On April 8, 2026, iBio announced it had received Clinical Trial Notification acknowledgement from Aust......

In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Zenas BioPharma, Inc., with a price target of $21.00. Fro......

An announcement from BioVersys AG ( ($CH:BIOV) ) is now available. BioVersys AG has convened its 2026 Annual General Meeting of shareholders for Ap......

BTIG analyst Julian Harrison maintained a Buy rating on Jade Biosciences on April 2 and set a price target of $39.00. The company’s shares closed l......

BTIG analyst Julian Harrison maintained a Buy rating on Jade Biosciences on April 2 and set a price target of $39.00. The company’s shares closed l......

Jade Biosciences ( ($JBIO) ) has provided an announcement. On March 31, 2026, Jade Biosciences, Inc.’s board approved the 2026 Employment Inducemen......

Mindbio Therapeutics Corp. ( ($TSE:MBIO) ) has issued an update. MindBio Therapeutics has closed an upsized non-brokered private placement, raising......

BioVaxys Technology ( ($TSE:BIOV) ) just unveiled an announcement. BioVaxys Technology Corp., a clinical-stage biopharmaceutical company focused on......